Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Humana (HUM)
:HUM
Holding HUM?
Track your performance easily
Earnings Data
Report Date
Feb 11, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-2.19Last Year’s EPS
-0.11Same Quarter Last Year
Moderate Buy
Based on 18 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2018
|% Change Since: 10.03%
|Next Earnings Date:Aug 01, 2018
Earnings Call Sentiment|Neutral
Humana reported exceeding expectations for the quarter and showed strong membership growth and operational efficiency. However, significant challenges remain with Stars ratings and specialty drug costs, along with increased investment needs impacting near-term earnings. While confidence in long-term potential is high, the company faces dynamic industry conditions and membership loss due to plan exits.Company Guidance
During Humana's Q3 2024 earnings call, the company provided several financial metrics and guidance for the future. Humana reported exceeding expectations for the quarter and confidently projected achieving at least $16 of EPS for the full year while expressing comfort with the 2024 EPS consensus. The company anticipates individual Medicare Advantage (MA) membership growth of about 5% for the year, highlighting disciplined product pricing and marketing investments. Humana's adjusted operating cost ratio is expected to decrease by 30 basis points for the year, and the company is targeting a 2025 Investor Day to provide further clarity on its multiyear outlook. The executives emphasized investments in Stars, growth, administrative cost efficiency, and medical cost management. Humana is also planning to add approximately 40 primary care clinics in 2024 and is optimistic about continued growth despite the challenges in the Stars ratings, aiming for a 3% margin target by 2027, albeit acknowledging the associated risks and necessary investments.Exceeded Quarterly Expectations
Humana exceeded expectations for Q3 and is confident in achieving at least $16 EPS for the full year 2024.
Medicare Advantage Membership Growth
Individual MA membership growth is anticipated to be around 5% year-over-year, outpacing expectations.
Customer Experience Recognition
Ranked as the #1 health insurer for customer experience by Forrester for the fourth consecutive year.
Efficient Back Office Operations
Projected a 30 basis point decrease in adjusted operating cost ratio, partly due to AI implementation.
Growth in Primary Care Clinics
Expect to add around 40 clinics this year, with patient growth exceeding expectations.
---
HUM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
HUM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $256.87 | $265.39 | +3.32% |
| Jul 31, 2024 | $402.00 | $359.35 | -10.61% |
| Apr 24, 2024 | $325.14 | $313.24 | -3.66% |
| Jan 25, 2024 | $397.90 | $351.39 | -11.69% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Humana (HUM) report earnings?
Humana (HUM) is schdueled to report earning on Feb 11, 2025, TBA Not Confirmed.
What is Humana (HUM) earnings time?
Humana (HUM) earnings time is at Feb 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HUM EPS forecast?
HUM EPS forecast for the fiscal quarter 2024 (Q4) is -2.19.
---
